IPO Trending
SAROJASME / NSEListed
Saroja Pharma Industries India

Saroja Pharma Industries India Limited, incorporated in 2019, is engaged in trading, exporting, and supplying specialty chemicals and APIs. The company deals in three major product categories: chemicals, pharma intermediaries, and veterinary pharma APIs. It supplies products like Liquid Bromine (used as an agro-intermediate), Ethyl Acetate (used as an API solvent), and other pharma-based chemicals used in human and veterinary medicines. APIs or bulk actives are the key ingredients used in producing finished dosage forms like tablets, capsules, and liquids. The company exports its products to international markets including Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore, and more.

₹84 - ₹848.86x sub
Listed Price₹65.00
Listing Gain-22.62%

Subscription Status

8.86xTotal Demand
Updated 20 Oct 2026, 01:30 AM
Nib2.98x
Fully Subscribed (Safe)Offered: 5,15,200 sh
Retail14.74x
Hot Bidding (High Profits)Offered: 5,15,200 sh
CategoryOfferedAppliedTimes
Nib5,15,20015,36,0002.98x
Retail5,15,20075,95,20014.74x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
Retail63.84.3314.73x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Saroja Pharma Industries India IPO Subscription Demand

Live subscription status and bidding analysis for Saroja Pharma Industries India (SAROJA) IPO. The issue is subscribed 8.86x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions